These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1058 related items for PubMed ID: 32437258

  • 1. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N, Kurian J, Agarwal V, Bhadauria D, Behera M, Yacha M, Kushwaha R, Agrawal V, Jain M, Gupta A.
    Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
    [Abstract] [Full Text] [Related]

  • 2. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
    Contreras G, Tozman E, Nahar N, Metz D.
    Lupus; 2005 Jul; 14 Suppl 1():s33-8. PubMed ID: 15803929
    [Abstract] [Full Text] [Related]

  • 3. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ, Palmer SC, Henderson L, Masson P, Craig JC, Tong A, Singh-Grewal D, Flanc RS, Roberts MA, Webster AC, Strippoli GF.
    Cochrane Database Syst Rev; 2018 Jun 29; 6(6):CD002922. PubMed ID: 29957821
    [Abstract] [Full Text] [Related]

  • 4. Sequential therapies for proliferative lupus nephritis.
    Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D.
    N Engl J Med; 2004 Mar 04; 350(10):971-80. PubMed ID: 14999109
    [Abstract] [Full Text] [Related]

  • 5. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM, Tse KC, Tang CS, Mok MY, Li FK, Hong Kong Nephrology Study Group.
    J Am Soc Nephrol; 2005 Apr 04; 16(4):1076-84. PubMed ID: 15728784
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R.
    J Rheumatol; 2015 Nov 04; 42(11):2082-91. PubMed ID: 26373566
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil or cyclophosphamide in indian patients with lupus nephritis: Which is better? A single-center experience.
    Mendonca S, Gupta D, Ali S, Gupta P.
    Saudi J Kidney Dis Transpl; 2017 Nov 04; 28(5):1069-1077. PubMed ID: 28937065
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan 04; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 9. Treatment for lupus nephritis.
    Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GF, Webster AC.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD002922. PubMed ID: 23235592
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.
    Ren Fail; 2008 Dec 12; 30(9):865-9. PubMed ID: 18925525
    [Abstract] [Full Text] [Related]

  • 11. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M, Goyal A, Jaryal A, Sharma A, Gupta PK, Ramachandran R, Kumar V, Kohli HS, Sakhuja V, Jha V, Gupta KL.
    Kidney Int; 2016 Jan 12; 89(1):235-42. PubMed ID: 26489028
    [Abstract] [Full Text] [Related]

  • 12. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
    Henderson LK, Masson P, Craig JC, Roberts MA, Flanc RS, Strippoli GF, Webster AC.
    Am J Kidney Dis; 2013 Jan 12; 61(1):74-87. PubMed ID: 23182601
    [Abstract] [Full Text] [Related]

  • 13. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
    Joo YB, Kang YM, Kim HA, Suh CH, Kim TJ, Park YW, Lee J, Lee JH, Yoo DH, Bae SC, Lee HS, Bang SY.
    Int J Rheum Dis; 2018 May 12; 21(5):1031-1039. PubMed ID: 29611341
    [Abstract] [Full Text] [Related]

  • 14. Long-term renal survival of paediatric patients with lupus nephritis.
    Demir S, Gülhan B, Özen S, Çeleğen K, Batu ED, Taş N, Orhan D, Bilginer Y, Düzova A, Ozaltin F, Topaloğlu R.
    Nephrol Dial Transplant; 2022 May 25; 37(6):1069-1077. PubMed ID: 33826705
    [Abstract] [Full Text] [Related]

  • 15. Lupus nephritis: maintenance therapy for lupus nephritis--do we now have a plan?
    Lenz O, Waheed AA, Baig A, Pop A, Contreras G.
    Clin J Am Soc Nephrol; 2013 Jan 25; 8(1):162-71. PubMed ID: 22917704
    [Abstract] [Full Text] [Related]

  • 16. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis.
    Jesus D, Rodrigues M, da Silva JAP, Inês L.
    Lupus; 2018 Jul 25; 27(8):1358-1362. PubMed ID: 29448882
    [Abstract] [Full Text] [Related]

  • 17. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.
    Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, MAINTAIN Nephritis Trial Group.
    Ann Rheum Dis; 2010 Dec 25; 69(12):2083-9. PubMed ID: 20833738
    [Abstract] [Full Text] [Related]

  • 18. The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis.
    Baskin E, Ozen S, Cakar N, Bayrakci US, Demirkaya E, Bakkaloglu A.
    Pediatr Nephrol; 2010 Jan 25; 25(1):111-7. PubMed ID: 19727839
    [Abstract] [Full Text] [Related]

  • 19. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S, Berden JH, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Dutch Working Party on SLE.
    Neth J Med; 2014 Nov 25; 72(9):481-90. PubMed ID: 25431394
    [Abstract] [Full Text] [Related]

  • 20. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.
    Lupus; 2018 Apr 25; 27(4):647-656. PubMed ID: 29105558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.